Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FRQW6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,838
Award facts
- Contract value 100% obligated
- $6,837.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,837.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and certain asthma presentations, representing specialized pharmaceutical support for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. The parent contract enables AmerisourceBergen to supply an extensive range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen demonstrates capability to fulfill specialized pharmaceutical requirements through competitive federal procurement processes.
Quick answers
Who was awarded contract SPE2DB25FRQW6?
SPE2DB25FRQW6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FRQW6 worth?
The government has obligated $6,838 on SPE2DB25FRQW6.
Is contract SPE2DB25FRQW6 an order under another contract?
Yes. SPE2DB25FRQW6 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRQW6 competed?
The extent of competition for SPE2DB25FRQW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award